The estimated Net Worth of David M Knott is at least $51.2 Million dollars as of 12 April 2016. David Knott owns over 157,853 units of Ligand Pharmaceuticals stock worth over $26,817,317 and over the last 18 years David sold LGND stock worth over $24,383,301.
David has made over 31 trades of the Ligand Pharmaceuticals stock since 2006, according to the Form 4 filled with the SEC. Most recently David sold 157,853 units of LGND stock worth $135,754 on 12 April 2016.
The largest trade David's ever made was selling 1,410,950 units of Ligand Pharmaceuticals stock on 21 March 2007 worth over $5,361,610. On average, David trades about 52,181 units every 61 days since 2006. As of 12 April 2016 David still owns at least 260,135 units of Ligand Pharmaceuticals stock.
You can see the complete history of David Knott stock trades at the bottom of the page.
David's mailing address filed with the SEC is 485 UNDERHILL BLVD, SUITE 205, SYOSSET, NY, 11791.
Over the last 21 years, insiders at Ligand Pharmaceuticals have traded over $205,340,014 worth of Ligand Pharmaceuticals stock and bought 2,116,600 units worth $27,601,439 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Partners L P/Ilbiotechnolog..., and Partners L P/Ilbiotechnolog.... On average, Ligand Pharmaceuticals executives and independent directors trade stock every 22 days with the average trade being worth of $2,239,733. The most recent stock trade was executed by Octavio Espinoza on 28 August 2024, trading 753 units of LGND stock currently worth $50,090.
ligand, a pharmaceutical company, is assembling a large and diverse portfolio of current and near-term commercial revenue generating assets to assist the long-term financial growth of the company. we operate this business on a lean cost structure that allows us to maximize cash flow and ultimately deliver a meaningful return for our shareholders.
Ligand Pharmaceuticals executives and other stock owners filed with the SEC include: